Heart failure management can feel like a never-ending list of meds and exceptions—until you anchor it to a space you can walk through. This post gives you a memory palace you can “tour” on test day to recall the high-yield HF treatment algorithm (especially HFrEF), plus quick USMLE-trigger facts and contraindications.
The Memory Palace: “The Heart Failure House” (Treatment Algorithm Tour)
Picture a house with 6 rooms you always visit in the same order. Each room = a treatment step. If you can “walk the house,” you can write the algorithm.
1) Front Porch: “Are they crashing?” (Acute decompensation first)
One-liner: If they’re unstable, stabilize before optimizing chronic meds.
On the porch, check the “doorbell vitals”:
- Hypotension, shock, altered mental status, severe respiratory distress → ICU-level care
- Flash pulmonary edema → NIV (BiPAP) + IV loop diuretic ± nitroglycerin (if BP allows)
Acute HF quick hits (Step-style):
- Wet + warm (congested but perfusing): IV loop diuretics (furosemide/bumetanide) are first-line
- Wet + cold (congested + hypoperfused): consider inotrope (dobutamine/milrinone) + cautious diuresis; evaluate for cardiogenic shock
- Cardiogenic shock after MI: norepinephrine often used for pressure support + definitive revascularization; consider mechanical support
Pearl: When acutely decompensated, hold/avoid starting beta-blockers if the patient is in shock, severely bradycardic, or requiring inotropes.
2) Foyer: “Is it HFrEF or HFpEF?” (EF decides the pathway)
One-liner: EF determines which meds are mortality-reducing.
- HFrEF: EF ≤ 40% → focus on mortality benefit meds
- HFpEF: EF ≥ 50% (and 41–49% “HFmrEF”) → focus on BP control, diuresis, comorbids, and select agents
High-yield diagnostic hook:
- S3: classically associated with HFrEF/dilated physiology
- S4: classically associated with stiff ventricle (often HFpEF, long-standing HTN)
The Core Algorithm (HFrEF): “The Big 4 Live in the Living Room”
3) Living Room: The “Big 4” Foundation (start early, titrate up)
One-liner: For symptomatic chronic HFrEF, start the Big 4—these change survival.
| “Big 4” Drug Class | Examples | What it improves | USMLE trigger contraindications / cautions |
|---|---|---|---|
| ARNI (preferred) or ACEi/ARB | Sacubitril/valsartan; enalapril; losartan | ↓ mortality, ↓ hospitalizations | Pregnancy, history of angioedema; hyperK, AKI risk; ARNI needs 36-hr washout after ACEi |
| Evidence-based beta-blocker | Metoprolol succinate, carvedilol, bisoprolol | ↓ mortality, ↓ sudden death | Start when euvolemic; avoid/initiate cautiously in acute decomp, severe bradycardia, heart block |
| Mineralocorticoid receptor antagonist (MRA) | Spironolactone, eplerenone | ↓ mortality (esp. NYHA II–IV) | K+ ≥ 5.0, eGFR < 30; spironolactone → gynecomastia |
| SGLT2 inhibitor | Dapagliflozin, empagliflozin | ↓ mortality/hosp (even without DM) | Genital infections; euglycemic DKA (rare); hold peri-op/acute illness |
How to remember the Big 4 in the Living Room:
- Armchair = ARNI/ACEi/ARB
- Bookshelf = Beta-blocker
- Salt lamp = Spironolactone (MRA)
- Thermostat = T2 inhibitor (SGLT2)
Rapid Step 2 nuance: You can start low-dose elements of the Big 4 quickly (often within days) as long as BP/renal function allow—then titrate.
4) Kitchen: “Get the fluid out” (Diuretics = symptom control)
One-liner: Diuretics make patients feel better; they don’t drive the mortality benefit like the Big 4.
- Loop diuretics: furosemide, bumetanide, torsemide
- Add thiazide-like (metolazone) for diuretic resistance (watch electrolytes)
High-yield adverse effects:
- Loop diuretics → hypokalemic metabolic alkalosis, ototoxicity (rare), sulfa allergy (except ethacrynic acid)
Memory cue: The kitchen sink is overflowing → loop diuretic to “drain the sink.”
Add-On Rooms: “If they’re still symptomatic…”
5) Hallway Closet: “Special keys for special doors” (Add-on therapies)
One-liner: If Big 4 + diuretics aren’t enough, add targeted meds based on the patient’s profile.
A) Hydralazine + isosorbide dinitrate
- Best-known high-yield use: Black patients with HFrEF (added to standard therapy)
- Also helpful if ACEi/ARB/ARNI not tolerated (e.g., renal dysfunction, hyperK)
- Watch: headaches, hypotension; hydralazine → drug-induced lupus risk
B) Ivabradine
- Use when: sinus rhythm, HR ≥ 70, LVEF ≤ 35%, on max tolerated beta-blocker
- Mechanism: blocks If (“funny”) current in SA node → ↓ HR without lowering BP much
C) Digoxin
- Symptom/hospitalization reduction (not a primary mortality drug)
- Toxicity: GI + neuro + arrhythmias; classic ECG: scooped ST
- Toxicity risk ↑ with hypokalemia (e.g., from diuretics)
Closet image: A “special tool kit” labeled HIN = Hydralazine/Isosorbide, Ivabradine, Na+/K+ pump (Digoxin).
6) Garage: “Devices & advanced therapies”
One-liner: If meds aren’t enough—or arrhythmia risk is high—think devices.
ICD (implantable cardioverter-defibrillator)
- Primary prevention: LVEF ≤ 35% despite optimal GDMT, appropriate survival expectancy
- Prevents sudden cardiac death (ventricular arrhythmias)
CRT (cardiac resynchronization therapy)
- Best test cue: wide QRS (often LBBB), symptomatic HFrEF
- Improves synchrony → ↑ EF, ↓ symptoms
LVAD / Transplant
- End-stage refractory HF despite GDMT and devices
Garage image: A car battery jumper = ICD (shocks); a dual-engine alignment tool = CRT (resynchronizes).
HFpEF Mini-Algorithm: “The Upstairs is Stiff”
One-liner: HFpEF = treat congestion + comorbidities (especially HTN, AF, ischemia).
High-yield approach:
- Diuretics for congestion (symptom control)
- Aggressive BP control
- Manage AF (rate/rhythm + anticoagulation as indicated)
- Consider SGLT2 inhibitor (evidence supports reduced HF hospitalizations in HFpEF/HFmrEF)
- Lifestyle/comorbids: obesity, OSA, diabetes, CAD
Classic Step 1 path: HFpEF often due to LV hypertrophy from long-standing HTN → diastolic dysfunction.
The “One Screenshot” Mnemonic (Shareable)
HOUSE for HFrEF
- Hemodynamics first (unstable? treat acute decomp/shock)
- Outflow fluid (loop diuretics for congestion)
- Upgrade survival meds (Big 4: ARNI/ACE/ARB + BB + MRA + SGLT2i)
- Select add-ons (H-ISDN, ivabradine, digoxin)
- Equipment (ICD/CRT/LVAD/transplant)
Rapid-Fire USMLE High-Yield Pitfalls (Don’t Miss These)
- Do not combine ACEi with ARNI; 36-hour washout required → prevents angioedema
- Beta-blockers: start when euvolemic, not in active shock
- Spironolactone: avoid if K+ high or renal failure (eGFR < 30)
- Diuretics improve symptoms but Big 4 improve mortality
- S3 = volume overload/dilated ventricle (often HFrEF); S4 = stiff ventricle (often HFpEF)
- Post-MI HFrEF: ACEi/ARB/ARNI + evidence BB + MRA are especially important (watch renal/K)
10-Second Case Walkthrough (How to Use the Palace)
A 62-year-old with dyspnea, edema, EF 25%, BP 122/78, Cr 1.1, K 4.4:
- Porch: stable, not crashing
- Foyer: HFrEF
- Living room: start/titrate ARNI + BB + MRA + SGLT2i
- Kitchen: add loop diuretic for symptoms
- Closet: if HR high despite BB → ivabradine; consider H-ISDN if indicated
- Garage: if EF remains ≤35% after GDMT → consider ICD (and CRT if wide QRS)